These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2130008)

  • 41. [Increase of rabbit tracheo-nasal mucus secretion by a new mucolytic agent: brovanexine (UR-389) (author's transl)].
    García-Rafanell J; Bellés L; Morell J
    Arch Farmacol Toxicol; 1976 Apr; 2(1):61-8. PubMed ID: 1275572
    [No Abstract]   [Full Text] [Related]  

  • 42. [Physicochemical characteristics of the tracheobronchial mucous secretion of lambs. Modification by a new mucolytic agent (Brovanexine UR-389)].
    Garcia-Rafanell J; Lleonart F
    Therapie; 1976; 31(4):483-90. PubMed ID: 12589
    [No Abstract]   [Full Text] [Related]  

  • 43. Tracheobronchial function in health and disease. Effect of mucolytic substances.
    Melville GN; Ismail S; Sealy C
    Respiration; 1980; 40(6):329-36. PubMed ID: 7221201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expectorant and antioxidant activities of purified fumarprotocetraric acid from Cladonia verticillaris lichen in mice.
    de Barros Alves GM; de Sousa Maia MB; de Souza Franco E; Galvão AM; da Silva TG; Gomes RM; Martins MB; da Silva Falcão EP; de Castro CM; da Silva NH
    Pulm Pharmacol Ther; 2014 Apr; 27(2):139-43. PubMed ID: 23872116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A complementary experimental method to study agents with mucolytic activity].
    Canellas J; Roquebert J; Dufour P; Demichel P
    Poumon Coeur; 1977; 33(5):281-5. PubMed ID: 594000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [In vivo and in vitro anti-viscosity activity of sobrerol].
    Scuri R; Frova C; Fantini PL; Mondani G; Alfieri C
    Farmaco Prat; 1981 Jan; 36(1):36-48. PubMed ID: 6164567
    [No Abstract]   [Full Text] [Related]  

  • 47. [Bronchial expectorants : pharmacology of bronchial mucomodifiers].
    Polu JM; Puchelle E; Sadoul P
    Sem Hop; 1984 Feb; 60(9):643-58. PubMed ID: 6324374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A simple method for the determination of the thread-forming property of tracheobronchial secretions.
    Iravani J; Melville GN
    Respiration; 1976; 33(4):289-93. PubMed ID: 7008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Model systems for the evaluation of mucolytic drugs: acetylcysteine and S-carboxymethylcysteine.
    Livingstone CR; Andrews MA; Jenkins SM; Marriott C
    J Pharm Pharmacol; 1990 Feb; 42(2):73-8. PubMed ID: 1972405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacological effects of brovanexine hydrochloride (BR-222) on the respiratory tract system, particularly on the respiratory tract fluid, mucociliary transport and cough].
    Kasé Y; Hidaka T; Miyata T; Takahama K; Okano Y; Kubo S; Yamazaki M
    Nihon Yakurigaku Zasshi; 1984 Feb; 83(2):173-81. PubMed ID: 6745807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Raxofelast, (+/-)5-(acetyloxy)-2,3-dihydro-4,6,7-trimethyl-2-benzofuranacetic acid: a new antioxidant to modulate the inflammatory response during ischemia-reperfusion injury and impaired wound healing.
    Bitto A; Minutoli L; Squadrito F; Polito F; Altavilla D
    Mini Rev Med Chem; 2007 Mar; 7(3):339-43. PubMed ID: 17346222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Activity of sobrerol on the production and transport of tracheobronchial mucus in experimental animals].
    Scuri R; Frova C; Fantini PL; Mondani G
    Boll Chim Farm; 1981 Jul; 120(7):392-9. PubMed ID: 7317165
    [No Abstract]   [Full Text] [Related]  

  • 53. [Problems in visiometry examining tracheo-bronchial-secretions (author's transl)].
    Heiden CL; Kornmesser HJ; Kretschmann A
    Laryngol Rhinol Otol (Stuttg); 1979 Mar; 58(3):264-8. PubMed ID: 439991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of mucolytic activity using a purified mucus glycoprotein gel.
    Marriott C; Brown DT; Beeson MF
    Adv Exp Med Biol; 1982; 144():93-5. PubMed ID: 7080945
    [No Abstract]   [Full Text] [Related]  

  • 55. Sobrerol: New Perspectives to Manage Patients with Frequent Respiratory Infections.
    Ciprandi G; Varriccchio A
    Children (Basel); 2023 Jul; 10(7):. PubMed ID: 37508708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expectorant action of inhaled alcohol.
    Boyd EM; Sheppard EP
    Arch Otolaryngol; 1969 Sep; 90(3):374-9. PubMed ID: 5807994
    [No Abstract]   [Full Text] [Related]  

  • 57. The development of an in vivo model for the evaluation of drugs affecting tracheal mucus.
    Readman AS; Marriott C; Barrett-Bee K
    Adv Exp Med Biol; 1982; 144():419-21. PubMed ID: 7080938
    [No Abstract]   [Full Text] [Related]  

  • 58. Mucosecretolytic effect of 1-methyl-4-(2-hydroxy-isopropyl)-cyclohex-1,2-en-6-ol (sobrerol) in the rabbit.
    Scuri R; Cellari C; Dalla Valle V
    Boll Chim Farm; 1976 Aug; 115(8):581-4. PubMed ID: 1016613
    [No Abstract]   [Full Text] [Related]  

  • 59. 2-(2,3-Dihydro-5-acetoxy-4,6,7-tribenzofuranyl)acetic acid (IRFI 016): a new antioxidant mucoactive drug.
    Scuri R; Giannetti P; Paesano A
    Drugs Exp Clin Res; 1990; 16(12):649-56. PubMed ID: 2130008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nesosteine: a new mucoregulatory agent.
    Scuri R; Mondani P; Frova C; Fantini L
    Drugs Exp Clin Res; 1986; 12(8):663-70. PubMed ID: 3757762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.